Insights

Get in Touch

Our Locations

Patrick Hurban, Ph.D.

Precision Medicine – Leveraging Genomics in Clinical Research

Part one

In part one of a three-part video series, Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q²Solutions, discusses the significance of genomic technologies in clinical trials.

Watch Dr. Hurban share his perspective on genomic technologies and the future of precision medicine as well as how both will impact healthcare globally.

Related Services & Solutions

Related Thought Leaders Insights

White Paper

Ensemble-based method for detecting differential expression in RNA datasets provides greater sensitivity and less biased p-values than existing methods

In examining two-group differential analysis, it is apparent that different statistical methods can yield very different results even given the same RNA-Seq input data. In particular, we have...

White Paper

Assay development, validation, and manufacturing with built-in quality controls

With more than 25 years of experience, Rules-Based Medicine, a Q² Solutions company develops, validates and manufactures its assays with integrity and commitment for the most reliable, reproducible...

Scientific Poster

Unleashing the power of MHC Associated Peptide Proteomics: Immunogenicity Assessment of Oncology Drugs

By Chloe Ackaert, Jana Schockaert, Aurelie Mazy, Martijn Vlaming, and Sofie PattynPresented at the American Association for Cancer Research (AACR) Annual Meeting, April 5-10, 2024 Bispecifics...